Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $31.7700 (-4.16%) ($31.2500 - $33.4600) on Mon. Apr. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.61% (three month average) | RSI | 17 | Latest Price | $31.7700(-4.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -9.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.305% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.305% (StdDev 4.61%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
1 - 5 Day Possible Target | $18.35(-42.24%) | Resistance Level | $38.12 | 5 Day Moving Average | $33.43(-4.97%) | 10 Day Moving Average | $35.63(-10.83%) | 20 Day Moving Average | $38.12(-16.66%) | To recent high | -27.9% | To recent low | 6.5% | Market Cap | $1.973b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |